| Next 10 |
Ad
CGIX News and Press Cancer Genetics Inc.
-
Over the past decade, scientists have been exploring vaccination as a way to help fight cancer. These experimental cancer vaccines are designed to stimulate the body’s own immune system to destroy a tumor, by injecting fragments of cancer proteins found on the tumor. So far, none of the...
-
Cancer Genetics, Inc. Renamed to Vyant Bio, Inc. Vyant Bio, Inc. will begin trading on Nasdaq under the symbol VYNT CHERRY HILL, N.J., March 31, 2021 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company” or “CGI”) (Nasdaq: CGIX), an emerg...
-
Cancer Genetics shares jump ([[CGIX]] +12.0%) after announcing shareholder approval of all proposals in connection with the proposed merger with stemonix.The definitive agreements to acquire acquire all of the outstanding capital stock of StemoniX in exchange for common sh...
-
Combined entity creates an innovative platform to de-risk and accelerate the discovery and development of preclinical and clinical pipelines with biopharma partners as well as the proprietary pipeline of the combined company RUTHERFORD, N.J., March 25, 2021 (GLOBE NEWSWIRE) ...
-
RUTHERFORD, N.J., March 18, 2021 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), an emerging leader in novel drug discovery techniques, announced today the appointment of Roland J. Carrillo, PhD as the Vice President of Business Development. ...
-
The following slide deck was published by Cancer Genetics, Inc. in conjunction with this event. For further details see: Cancer Genetics (CGIX) Investor Presentation - Slideshow
-
RUTHERFORD, N.J., March 12, 2021 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), an emerging leader in novel drug discovery techniques, announced today that Jay Roberts, Chief Executive Officer, will present at the Annual 33 rd ROTH Conferen...
-
RUTHERFORD, N.J., March 04, 2021 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), an emerging leader in novel drug discovery techniques, announced today that Jay Roberts, Chief Executive Officer, will present at H.C. Wainwright’s Global Life...
-
Tengasco (TGC) -28% on reverse stock split announcement.Tricida TCDA -26% after FDA rejected appeal for chronic kidney disease trial.TDH Holdings (PETZ) -16%.The9 NCTY -16%.Pintec Technology (PT) -15%.United States Antimony (UAMY) -4%.Virgin Galactic SPCE -14%&#x...
-
Gainers: Sypris Solutions (SYPR) +83%.9F (JFU) +39%.Owens & Minor (OMI) +38%.Sunworks (SUNW) +34%.R. R. Donnelley & Sons (RRD) +30%.Fisker (FSR) +28%.PubMatic (PUBM) +27%.dMY Technology (DMYI) +26%.Timber Pharmaceuticals (TMBR) +25%.Cancer Genetics (CGIX) +25%.Losers: C...
Stock Information
Get CGIX Alerts
News, Short Squeeze, Breakout and More Instantly...
Ad
